-
About UsBeijing Northland Biotechnology Co., Ltd. is an innovative biopharmaceutical company specializing in the research, development, production, and sales of gene therapy drugs, recombinant protein drugs, and ophthalmic drugs. -
R&D and ProductsPrimarily dedicated to the research, development, and industrialization of novel bioengineered drugs in areas such as cardiovascular diseases, metabolic disorders, rare diseases, and ophthalmic diseases. -
Investor RelationsGuided by the principle of “Creating Value, Serving Health,” the company is committed to becoming an innovative biopharmaceutical enterprise, contributing to the advancement of China’s pharmaceutical industry and the well-being of humanity.
NORTHLAND and the Affiliated Hospital of Chengde Medical College jointly held an academic conference on "Gene Therapy and Ischemic Diseases."
NORTHLAND and the Affiliated Hospital of Chengde Medical College jointly held an academic conference on “Gene Therapy and Ischemic Diseases.” At the conference, Dr. Jong-Mook Kim from South Korea’s ViroMed Company delivered a scholarly report titled “Gene Therapy for Ischemic Heart Disease,” introducing the current status and trends in the development of gene therapy drugs, and engaged in lively discussions with the attending experts. After the conference, NORTHLAND and the Affiliated Hospital of Chengde Medical College signed a cooperation agreement regarding the pharmacodynamic evaluation of NL003.
Share to:
Friendly Links: Baidu | NORTHLAND
Contact Information
Address: Room A406, Zhongguancun Biomedical Park, No. 5 Kaituo Road, Shangdi, Haidian District, Beijing
Follow Us
Northland is an innovative biopharmaceutical company specializing in the R&D, manufacturing and sales of gene therapy drugs, recombinant protein drugs and ophthalmic medications.
Web site
NL-BIO
NL003
NL005